Concepedia

Mengyao Xu

MX

Statistics

Publications

4

Citations

178

H-Index

4

Active since

2022

Affiliations

Affiliated Hospital of Southwest Medical University(Current)

Nankai University

Southwest Medical University

Mengyao Xu is an author at Affiliated Hospital of Southwest Medical University specializing in nanoparticle drug delivery, pharmaceutics, and poly(lactic-co-glycolic acid) nanoparticles.

ORCID

Publications per year

2022–2024

4

Publications

4

TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling

Xingkang Jiang, Shanqi Guo, Mengyao Xu et al. · Frontiers in Oncology · 2022 · 98 citations · Full text

, , +17

Fabrication, Optimization, and Evaluation of Paclitaxel and Curcumin Coloaded PLGA Nanoparticles for Improved Antitumor Activity

Haiyang Hu, Zuyue Liao, Mengyao Xu et al. · ACS Omega · 2022 · 35 citations · Full text

, , +17

Cancer cell membrane-camouflaged paclitaxel/PLGA nanoparticles for targeted therapy against lung cancer

Jiahan Zhou, Shengli Wan, Yuesong Wu et al. · Biomedicine & Pharmacotherapy · 2024 · 25 citations · Full text

, , +17

Microplastics could alter invasive plant community performance and the dominance of Amaranthus palmeri

Zirui Meng, Xunqiang Mo, Weiqing Meng et al. · The Science of The Total Environment · 2023 · 20 citations

, , +14

1–4 of 4